高级检索
当前位置: 首页 > 详情页

Human esophageal cancer endothelial cells increase tumor growth by incorporating with mouse endothelium

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Chinese Acad Med Sci, Canc Inst Hosp, Dept Cell & Mol Biol, Peking Union Med Coll, Beijing 100021, Peoples R China [2]China Japan Friendship Hosp, Inst Clin Med Sci, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: esophageal cancer tumor endothelial cells angiogenesis in vivo model

摘要:
Current in vivo investigations of tumor angiogenesis mainly rely on the results obtained from engrafted models in mice. In the present study, we attempt to assess the potential of human tumor endothelium to form neovasculature in different engrafted tumor models. The tumor endothelial cells were isolated from human esophageal squamous cell carcinoma, and then identified by anti-VEGFR1/2 immunoreactions and tube formation assay. Esophageal and lung cancer cells were subcutaneously inoculated into nude mice with human esophageal cancer endothelial cells (HECECs), respectively. The human umbilical vein endothelial cells (HUVECs) were also co-inoculated into mice with esophageal cancer cells as a control. The engrafted tumor growth was significantly promoted by co-inoculation of HECECs in comparison with injection of esophageal tumor cells alone. Immunohistochernistry of anti-CD31 and anti-huCD31 was performed to detect the micro-vessels in the engrafted tumors which revealed that the HECECs formed humanized micro-vessels and significantly increased the micro-vessel density in engrafted tumors comparing with the tumors without HECECs. However, HUVEC cells could not enhance the esophageal tumor growth and the growth of lung tumors could not be increased by HECECs, either. Few humanized blood vessels were found in these two groups of xenografts. These results suggest that the specific interaction between HECECs and esophageal tumor cells contributes to the neovasculature construction and esophageal tumor growth in xenografts. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2006]版:
大类 | 3 区 医学
最新[2025]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2005]版:
Q2 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2005版] 出版当年五年平均[2001-2005] 出版前一年[2004版] 出版后一年[2006版]

第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)